We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

81 hedge funds and large institutions have $250M invested in Fulcrum Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more call options, than puts

Call options by funds: $3.1M | Put options by funds: $1.24M

37% more capital invested

Capital invested by funds: $183M → $250M (+$67.2M)

1.33% more ownership

Funds ownership: 89.89% → 91.22% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 88 → 81 (-7)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

35% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 26

Holders
81
Holders Change
-7
Holders Change %
-7.95%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
17
Reduced
26
Closed
21
Calls
$3.1M
Puts
$1.24M
Net Calls
+$1.86M
Net Calls Change
-$36K

Top Buyers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
+$6.26M
2
CAC
Cowen and Company
New York
+$5.21M
3
Marshall Wace
Marshall Wace
United Kingdom
+$4.51M
4
Millennium Management
Millennium Management
New York
+$1.88M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.84M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.27M
2
WP
Woodline Partners
California
-$1.97M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.28M
4
HMC
Harvard Management Company
Massachusetts
-$1.13M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$1.04M +$1.02M +233,538 New
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$982K +$328K +75,042 +51%
Alyeska Investment Group
28
Alyeska Investment Group
Illinois
$898K – – –
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$872K +$859K +196,488 New
State Street
30
State Street
Massachusetts
$813K -$99.7K -22,800 -11%
RC
31
RBF Capital
California
$684K – – –
Northern Trust
32
Northern Trust
Illinois
$635K -$1.95K -446 -0.3%
Bank of America
33
Bank of America
North Carolina
$617K +$29.7K +6,806 +5%
FT
34
Fiduciary Trust
Massachusetts
$606K – – –
AI
35
Acuitas Investments
Washington
$599K -$17 -4 -0%
BCM
36
Bridgeway Capital Management
Texas
$562K – – –
CAM
37
ClariVest Asset Management
California
$464K +$456K +104,400 New
JF
38
Jump Financial
Illinois
$408K +$401K +91,790 New
Citigroup
39
Citigroup
New York
$396K +$355K +81,286 +1,029%
OQS
40
Occudo Quantitative Strategies
Florida
$388K +$382K +87,372 New
DA
41
Denali Advisors
California
$313K +$309K +70,600 New
Bank of New York Mellon
42
Bank of New York Mellon
New York
$272K -$4.95K -1,132 -2%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$268K +$262K +60,000 New
Squarepoint
44
Squarepoint
New York
$262K -$183K -41,891 -42%
Renaissance Technologies
45
Renaissance Technologies
New York
$234K -$1.28M -292,076 -85%
MA
46
MYDA Advisors
New York
$222K – – –
XT
47
XTX Topco
Cayman Islands
$173K -$193K -44,248 -53%
Jane Street
48
Jane Street
New York
$171K -$121K -27,792 -42%
American Century Companies
49
American Century Companies
Missouri
$164K +$37.2K +8,522 +30%
AG
50
Algert Global
California
$138K +$136K +31,010 New
1
2
3 4 5

FULC Hedge Fund Activity: Q3 2023 in Review

81 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q3 2023, worth a combined $250M — up 37% from $183M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of FULC and 15 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 17 added.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $6.26M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.27M sold.

  • 81 institutional investors held Fulcrum Therapeutics (FULC) as of Q3 2023, down from 88 in Q2 2023.
  • Funds reported $250M of Fulcrum Therapeutics stock for Q3 2023, up 37% quarter-over-quarter.
  • 15 funds opened new Fulcrum Therapeutics positions in Q3 2023 and 21 closed out, a net change of -6 holders.
  • The largest Fulcrum Therapeutics buyer in Q3 2023 was Jefferies Financial Group, an estimated $6.26M added.
  • The largest Fulcrum Therapeutics seller in Q3 2023 was Point72 Asset Management, an estimated $6.27M sold.

Based on aggregated 13F filings for Q3 2023.